Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema

Inclusion Criteria: * Clinically diagnosed super-infected or impetiginized eczema Exclusion Criteria: * Patients who have general signs of systemic infections like fever, malaise, lymphangitis or swollen lymph nodes and / or need systemic antibiotic treatment * Patients who have a bacterial skin infection which, due to depth and severity, could not be appropriately treated with a topical antimicrobial or antiseptic medication * Diagnose of the following disease: * Known active tuberculosis or any history of past tuberculosis of skin * Suspected or proven parasitic infection of the treatment site (e.g. scabies) * Psoriasis * Suspected or proven viral infection of skin (e.g. Herpes) * Localization of the superficial infected eczema: * Palms of the hands * Sole of a foot * Face * Have received any topical treatment with antibiotics, antimycotics, immunomodulators and corticosteroid preparations within the last 2 weeks before treatment with IMP